Clinical Trials Logo
  1. Home
  2. Bipolar Disorder
  3. NCT00036101
  4. Details
NCT00036101 Clinical Trial

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder

Bipolar Disorder Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00036101
Other study ID # CN138-074
Secondary ID
Status Completed
Phase Phase 3
First received May 7, 2002
Last updated November 7, 2013
Start date February 2002
Est. completion date January 2003

Study information
Verified date September 2007
Source Otsuka Pharmaceutical Development & Commercialization, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date January 2003
Est. primary completion date January 2003
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients with acute symptoms of Bipolar Disorder

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• aripiprazole

Locations
Country Name City State
United States Local Institution Austin Texas
United States Local Institution Beachwood California
United States Local Institution Bellevue Washington
United States Local Institution Belmont Massachusetts
United States Local Institution Butner North Carolina
United States Local Institution Chicago Illinois
United States Local Institution Chula Vista California
United States Local Institution Cincinnati Ohio
United States Local Institution Falls Church Virginia
United States Local Institution Honolulu Hawaii
United States Local Institution Houston Texas
United States Local Institution Indianapolis Indiana
United States Local Institution Lawrence New York
United States Local Institution Little Rock Arizona
United States Local Institution Louisville Kentucky
United States Local Institution Medina Ohio
United States Local Institution New Baltimore Michigan
United States Local Institution Newton Center Massachusetts
United States Local Institution North Miami Florida
United States Local Institution Philadelphia Pennsylvania
United States Local Institution Riverside California
United States Local Institution San Clemente California
United States Local Institution San Diego California
United States Local Institution Stanford California
United States Local Institution Tuscaloosa Alabama
United States Local Institution Washington District of Columbia
United States Local Institution Winter Park Florida

Sponsors (1)
Lead Sponsor Collaborator
Otsuka Pharmaceutical Development & Commercialization, Inc.

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT02855762 - Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder N/A
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT02513654 - Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects Phase 1
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Completed NCT02304432 - Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Early Phase 1
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT03497663 - VIA Family - Family Based Early Intervention Versus Treatment as Usual N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02212041 - Electronic Cigarettes in Smokers With Mental Illness N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Not yet recruiting NCT04432116 - Time and Virtual Reality in Schizophrenia and Bipolar Disorder N/A
Terminated NCT02909504 - Gao NARASD Lithium Study Phase 4
Terminated NCT02893371 - Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Completed NCT02970721 - Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Recruiting NCT03088657 - Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study

External Links